Sumit Aggarwal
2021
In 2021, Sumit Aggarwal earned a total compensation of $5.7M as Chief Executive Officer at Sevion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $331,250 |
|---|---|
| Option Awards | $4,011,367 |
| Salary | $407,692 |
| Stock Awards | $937,971 |
| Total | $5,688,280 |
Aggarwal received $4M in option awards, accounting for 71% of the total pay in 2021.
Aggarwal also received $331.3K in non-equity incentive plan, $407.7K in salary and $938K in stock awards.
Rankings
In 2021, Sumit Aggarwal's compensation ranked 2,236th out of 12,415 executives tracked by ExecPay. In other words, Aggarwal earned more than 82.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,236 out of 12,415 | 82nd |
Division Manufacturing | 876 out of 5,505 | 84th |
Major group Chemicals And Allied Products | 334 out of 2,375 | 86th |
Industry group Drugs | 289 out of 2,096 | 86th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 449 | 80th |
Source: SEC filing on April 28, 2023.
Aggarwal's colleagues
We found two more compensation records of executives who worked with Sumit Aggarwal at Sevion Therapeutics in 2021.